A Phase I, Single-Center, Double-Blind, Randomized, Placebo-Controlled Clinical Trial to Investigate the Safety, Tolerability and Pharmacokinetics of NRM8499 Administered as Single and Multiple Oral Doses to Healthy Young Males and Healthy Elderly Male and Female Subjects

Trial Profile

A Phase I, Single-Center, Double-Blind, Randomized, Placebo-Controlled Clinical Trial to Investigate the Safety, Tolerability and Pharmacokinetics of NRM8499 Administered as Single and Multiple Oral Doses to Healthy Young Males and Healthy Elderly Male and Female Subjects

Completed
Phase of Trial: Phase I

Latest Information Update: 20 Mar 2015

At a glance

  • Drugs ALZ 801 (Primary) ; Tramiprosate
  • Indications Alzheimer's disease
  • Focus Adverse reactions
  • Most Recent Events

    • 20 Mar 2015 Results presented at the 12th International Conference on Alzheimer's and Parkinson's Diseases, according to an Alzheon media release.
    • 31 Jan 2011 Inerim results have been reported for Part 1-3 (67 patients) in a BELLUS Health media release.
    • 31 Dec 2010 Status changed from recruiting to completed.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top